ENZALUTAMIDE for Prostatic specific antigen: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where ENZALUTAMIDE was used for Prostatic specific antigen.
Most Reported Side Effects for ENZALUTAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 8,891 | 18.1% | 594 | 1,115 |
| Death | 6,680 | 13.6% | 6,677 | 702 |
| Malignant neoplasm progression | 4,696 | 9.5% | 1,482 | 695 |
| Prostatic specific antigen increased | 3,731 | 7.6% | 321 | 463 |
| Asthenia | 3,589 | 7.3% | 386 | 785 |
| Drug ineffective | 3,468 | 7.0% | 235 | 275 |
| Hot flush | 3,144 | 6.4% | 119 | 262 |
| Decreased appetite | 3,069 | 6.2% | 413 | 811 |
| Nausea | 2,898 | 5.9% | 264 | 554 |
| Dizziness | 2,776 | 5.6% | 201 | 503 |
| Diarrhoea | 2,470 | 5.0% | 209 | 473 |
| Underdose | 2,017 | 4.1% | 393 | 320 |
| Back pain | 1,997 | 4.1% | 185 | 356 |
| Arthralgia | 1,821 | 3.7% | 114 | 243 |
| Constipation | 1,629 | 3.3% | 136 | 296 |
Other Indications for ENZALUTAMIDE
Prostate cancer (25,954)
Product used for unknown indication (9,434)
Hormone-refractory prostate cancer (8,881)
Prostate cancer metastatic (3,171)
Metastases to bone (439)
Neoplasm prostate (401)
Neoplasm malignant (297)
Hormone-dependent prostate cancer (289)
Bone cancer (213)
Prostate cancer stage iv (208)
Other Drugs Used for Prostatic specific antigen
GOLIMUMAB (848)
SECUKINUMAB (100)
SIRUKUMAB (47)
ADALIMUMAB (43)
METHYLPREDNISOLONE (30)
APREMILAST (23)
METHOTREXATE (18)
CERTOLIZUMAB PEGOL (15)
HYDROXYCHLOROQUINE (15)
TOFACITINIB (11)